NEO Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

03

Harga $18.47

Kapitalisasi Pasar (MRQ) $2.36B

P/E -77.9

Pendapatan $727M

ROE -12.8%

D/E Utang/Ekuitas (MRQ) 0.5

Rentang 52M $7–$20

NEO Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

04

rentang

batang

Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.

Tentang NeoGenomics, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia

05 · wikidata

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.

## History

NeoGenomics first received state and national-level laboratory certifications in 2002. Three years later in 2005, the company developed a technical-only service model using FISH.

In 2013, the company launched its sequencing platform and was listed on the Nasdaq Stock Market as NEO. In 2014, NeoGenomics launched molecular tests including BTK and CALR mutation analysis.

In 2015, NeoGenomics acquired Clarient, Inc. and its subsidiary company, Clarient Diagnostic Services, Inc., a national cancer diagnostics laboratory with capabilities in immunohistochemistry for solid tumor cancers from GE Healthcare. Clarient is headquartered in Aliso Viejo, California; with an ancillary laboratory in Houston, Texas.

In November 2017, NeoGenomics established their first headquarters outside the United States in Rolle, Switzerland.

In September 2024, the District Court for the Middle District of North Carolina entered a permanent injunction against NeoGenomics’ accused RaDaR assay, which was preliminarily enjoined in December 2023.

Baca selengkapnya Tampilkan lebih sedikit

Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗

Wikidata ↗

sektorHealth Care industriHealth Care karyawan2.500 negaraUS

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

06

Pendapatan$727M

2016-12-31 → 2025-12-31

Arus Kas Bebas$-22M

2017-12-31 → 2025-12-31

Margin bersih-6.8%

2019-12-31 → 2025-12-31

Valuasi & Rasio 07–12

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik	NEO	rata-rata 5T	Median Rekan	Kesimpulan
P/E	-77.9rata-rata 5T ≈-73.2	≈-73.2	·	·
P/S (TTM)	3.1rata-rata 5T ≈3.8	≈3.8	1.1	Terlalu mahal
P/B (MRQ)	3.0rata-rata 5T ≈2.2	≈2.2	2.4	Nilai wajar
EV / EBITDA	-22.2	·	·	·
Harga / FCF (TTM)	-321.2rata-rata 5T ≈-50.3	≈-50.3	·	·
Harga / Arus Kas (TTM)	107.2rata-rata 5T ≈-125.0	≈-125.0	13.5	Terlalu mahal
EV / Revenue (EV / Pendapatan)	3.5	·	·	·
EV / FCF	-118.3	·	·	·
Harga / Nilai Buku Berwujud (MRQ)	4.6rata-rata 5T ≈40.2	≈40.2	·	·

Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.

Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC

Metrik	NEO	rata-rata 5T	Median Rekan	Kesimpulan
Margin Kotor (TTM)	43.9%rata-rata 5T ≈40.8%	≈40.8%	32.6%	Tingkat teratas
Margin Operasi (TTM)	-8.9%rata-rata 5T ≈-20.7%	≈-20.7%	4.0%	Lemah
EBITDA Margin (Margin EBITDA)	-15.9%rata-rata 5T ≈-20.7%	≈-20.7%	4.5%	Lemah
Margin Sebelum Pajak (TTM)	-7.1%rata-rata 5T ≈-15.6%	≈-15.6%	3.3%	Lemah
Margin Laba Bersih (TTM)	-6.8%rata-rata 5T ≈-14.3%	≈-14.3%	2.4%	Lemah
ROA	-7.2%rata-rata 5T ≈-5.1%	≈-5.1%	1.8%	Lemah
ROE	-12.8%rata-rata 5T ≈-9.2%	≈-9.2%	3.3%	Lemah
ROIC	-9.6%rata-rata 5T ≈-9.3%	≈-9.3%	5.0%	Lemah

Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca

Metrik	NEO	rata-rata 5T	Median Rekan	Kesimpulan
Utang / Ekuitas (MRQ)	0.5	·	0.3	Utang tinggi
Rasio Lancar (MRQ)	3.6rata-rata 5T ≈5.4	≈5.4	1.5	Likuiditas kuat
Quick Ratio (Rasio Cepat)	3.6rata-rata 5T ≈3.9	≈3.9	1.2	Likuiditas kuat
Utang Jangka Panjang / Ekuitas (MRQ)	0.5	·	0.4	Utang tinggi

Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T

Metrik	NEO	rata-rata 5T	Median Rekan	Kesimpulan
Revenue YoY (Pendapatan YoY)	10.1%rata-rata 5T ≈10.4%	≈10.4%	·	·
Revenue CAGR 3Y (CAGR Pendapatan 3T)	12.6%rata-rata 5T ≈11.2%	≈11.2%	·	·
Revenue CAGR 5Y (CAGR Pendapatan 5T)	10.3%	·	·	·

Metrik Per Saham EPS, nilai buku per saham, arus kas per saham, dividen per saham

Metrik	NEO	rata-rata 5T	Median Rekan	Kesimpulan
Revenue / Share (Pendapatan / Saham)	$5.68rata-rata 5T ≈$4.75	≈$4.75	·	·
Cash Flow / Share (Arus Kas / Saham)	$0.04rata-rata 5T ≈$-0.13	≈$-0.13	·	·
Cash / Share (Kas / Saham)	$1.25rata-rata 5T ≈$2.35	≈$2.35	·	·

Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang

Metrik	NEO	rata-rata 5T	Median Rekan	Kesimpulan
Asset Turnover (Perputaran Aset)	0.5rata-rata 5T ≈0.4	≈0.4	1.6	Lemah
Inventory Turnover (Perputaran Persediaan)	14.9rata-rata 5T ≈13.7	≈13.7	·	·
Receivables Turnover (Perputaran Piutang)	4.7rata-rata 5T ≈4.6	≈4.6	8.4	Lemah
Revenue / Employee (Pendapatan Tahunan ÷ karyawan (jumlah karyawan, yfinance). Turunan — bukan konsep SEC-XBRL yang tersimpan.)	≈$290.9K	·	·	·

nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

14

Kejutan Rata-rata 55.4%

Laporan Berikutnya Okt 26, 2026

Periode	Laporan	EPS Aktual	EPS Estimasi	Kejutan
30 Juni 2026	Jul 27, 2026	$0.05	$0.03	51.1%
31 Maret 2026		$0.01	$0.01	—
31 Des. 2025		$0.06	$0.04	53.5%
30 Sep. 2025		$0.03	$0.02	40.8%
30 Juni 2025		$0.03	$0.02	31.6%
31 Maret 2025		$0.00	$-0.01	100.0%

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

15

Laporan Laba Rugi 18

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue	$727M	$661M	$592M	$510M	$484M	$444M	$409M	$277M	$240M	$232M	$5M	$5M
Cost of Revenue	$413M	$370M	$347M	$322M	$297M	$259M	$212M	$149M	$138M	$134M	$56M	$46M
Gross Profit	$314M	$290M	$245M	$188M	$187M	$186M	$197M	$127M	$102M	$98M	$44M	$41M
R&D Expense	$37M	$31M	$27M	$30M	$22M	$8M	$8M	$3M	$4M	$5M	$4M	$3M
SG&A Expense	$273M	$260M	$243M	$243M	$221M	$144M	$128M	$85M	$70M	$64M	$34M	$24M
Operating Expenses	$430M	$382M	$352M	$346M	$306M	$200M	$184M	$117M	$99M	$96M	$49M	$38M
Operating Income	$-116M	$-92M	$-108M	$-158M	$-119M	$-14M	$13M	$10M	$3M	$2M	$-6M	$2M
Interest Expense	·	·	$7M	$8M	$8M	$7M	$4M	$6M	$6M	·	$854.0K	$985.0K
Interest Income	$9M	$18M	$17M	$6M	$3M	·	·	·	·	·	·	·
Other Non-op	$296.0K	$-379.0K	$644.0K	$-213.0K	$-499.0K	$8M	$-5M	$14.0K	$-12.0K	$0	$2M	$56.0K
Pretax Income	$-110M	$-81M	$-97M	$-159M	$-15M	$-14M	$4M	$4M	$-3M	$-8M	$-4M	$1M
Income Tax	$-2M	$-2M	$-9M	$-15M	$-7M	$-18M	$-4M	$1M	$-2M	$-2M	$-2M	$157.0K
Net Income	$-108M	$-79M	$-88M	$-144M	$-8M	$4M	$8M	$3M	$-396.0K	$-6M	$-3M	$1M
EPS (Basic)	·	·	·	·	·	·	·	·	·	·	$-0.04	$0.02
EPS (Diluted)	·	·	·	·	·	·	·	·	·	·	$-0.04	$0.02
Shares (Basic)	128,101,000	126,658,000	125,502,000	124,217,000	119,962,000	108,579,000	100,470,000	85,618,000	79,426,000	77,542,000	60,526,000	53,483,000
Shares (Diluted)	128,101,000	126,658,000	125,502,000	124,217,000	119,962,000	111,794,000	103,615,000	91,568,000	79,426,000	77,542,000	60,526,000	56,016,000
EBITDA	$-116M	$-92M	$-108M	$-158M	$-119M	$-14M	$13M	·	$2M	·	$-6M	·

Neraca 29

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	$160M	$367M	$342M	$263M	$317M	$229M	$173M	$10M	$13M	$13M	$23M	$34M
Receivables	$159M	$151M	$131M	$120M	$112M	$107M	$94M	$77M	$60M	$56M	$49M	$20M
Inventory	$29M	$27M	$24M	$24M	$23M	$30M	$14M	$9M	$7M	$6M	$5M	$3M
Prepaid Expense	$21M	$20M	$18M	$15M	$12M	$12M	$6M	$8M	$5M	$5M	$5M	$1M
Other Current Assets	$7M	$12M	$8M	$8M	$8M	$5M	$3M	$561.0K	$1M	·	·	·
Current Assets	$376M	$596M	$597M	$605M	$682M	$449M	$291M	$104M	$86M	$79M	$82M	$59M
PP&E (Net)	$85M	$94M	$92M	$102M	$109M	$86M	$64M	$61M	$37M	$34M	$35M	$15M
PP&E (Gross)	$294M	$284M	$250M	$234M	$219M	$179M	$133M	$111M	$77M	$61M	$61M	$35M
Accum. Depreciation	$209M	$190M	$158M	$132M	$110M	$93M	$69M	$50M	$41M	$27M	$27M	$20M
Goodwill	$524M	$523M	$523M	$523M	$527M	$211M	$199M	$198M	$147M	$147M	$147M	$3M
Intangibles	$287M	$340M	$373M	$408M	$442M	$121M	$127M	$140M	$74M	$77M	$88M	$4M
Other Non-current Assets	$9M	$6M	$5M	$5M	$7M	$5M	$3M	$3M	$891.0K	$174.0K	$129.0K	$141.0K
Total Assets	$1.36B	$1.64B	$1.68B	$1.74B	$1.87B	$988M	$710M	$505M	$344M	$337M	$351M	$81M
Accounts Payable	$23M	$22M	$20M	$21M	$18M	$25M	$20M	$18M	$10M	$17M	$12M	$6M
Accrued Liabilities	·	·	·	·	·	·	·	·	·	·	·	$1M
Current Liabilities	$88M	$301M	$96M	$90M	$87M	$73M	$64M	$61M	$36M	$38M	$40M	$15M
Capital Leases	$63M	$61M	$68M	$69M	$72M	$42M	$24M	$5M	$5M	$5M	$5M	$5M
Deferred Tax	$18M	$22M	$24M	$35M	$55M	$5M	$16M	$22M	$7M	·	$16M	$821.0K
Other Non-current Liabilities	$12M	$12M	$13M	$13M	$14M	$4M	$4M	$3M	$283.0K	·	·	·
Total Liabilities	$523M	$736M	$740M	$742M	$762M	$294M	$202M	$185M	$140M	$151M	$113M	$21M
Long-term Debt	$342M	$541M	$538M	·	·	·	·	$102M	$97M	$98M	$55M	·
Total Debt	$342M	$541M	·	·	·	$0	·	·	$95M	·	$53M	·
Common Stock	·	·	·	·	·	·	·	·	·	·	·	$60.0K
Retained Earnings	$-434M	$-326M	$-247M	$-159M	$-15M	$-7M	$-11M	$-19M	$-58M	$-52M	$-22M	$-19M
Treasury Stock	$0	·	·	·	·	·	·	·	·	·	·	·
AOCI	$4.0K	$-206.0K	$-2M	$-4M	$-638.0K	$10.0K	$-2M	$-579.0K	$274.0K	·	·	·
Stockholders' Equity	$837M	$902M	$942M	$998M	$1.11B	$694M	$507M	$320M	$172M	$162M	$209M	$60M
Liabilities + Equity	$1.36B	$1.64B	$1.68B	$1.74B	$1.87B	$988M	$710M	$505M	$344M	$337M	$351M	$81M
Shares Outstanding	128,989,152	128,145,333	127,369,142	126,913,992	124,107,500	112,075,474	104,781,236	94,465,440	80,462,574	78,571,158	75,820,307	60,242,818

Arus Kas 15

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
D&A	·	·	·	·	·	$26M	$20M	$16M	$16M	$16M	$7M	$5M
Stock-based Comp	$41M	$33M	$25M	$25M	$22M	$10M	$10M	$7M	$6M	$5M	$3M	$641.0K
Deferred Tax	$-3M	$-3M	$-10M	$-15M	$-7M	$-18M	$-4M	$2M	$-2M	$-2M	$-2M	·
Amort. of Intangibles	$32M	$33M	$35M	$34M	$23M	$10M	$10M	$6M	$7M	$7M	$412.0K	$295.0K
Restructuring	$0	$7M	$11M	$5M	$0	$0	·	·	·	·	·	·
Operating Cash Flow	$5M	$7M	$-2M	$-66M	$-27M	$1M	$23M	$45M	$18M	$21M	$6M	$9M
CapEx	$27M	$41M	$29M	$31M	$64M	$29M	$20M	$14M	$14M	$8M	$2M	$4M
Investing Cash Flow	$-12M	$13M	$77M	$517.0K	$-632M	$-159M	$-20M	$-140M	$-14M	·	·	·
Stock Issued	$962.0K	$5M	$5M	$13M	$15M	$20M	$11M	$9M	$3M	·	·	$34M
Net Stock Activity	$962.0K	$5M	$5M	$13M	$15M	$20M	$11M	·	·	·	·	·
Financing Cash Flow	$-200M	$5M	$5M	$12M	$725M	$236M	$159M	$92M	$-4M	·	·	·
Net Change in Cash	·	·	·	·	·	$78M	$163M	$-3M	$296.0K	$-11M	$-10M	$29M
Taxes Paid	$515.0K	$207.0K	$175.0K	$180.0K	$148.0K	$246.0K	$319.0K	$-31.0K	$284.0K	$290.0K	·	·
Free Cash Flow	$-22M	$-34M	$-31M	$-97M	$-91M	$-28M	$3M	·	$4M	·	$4M	·
Levered FCF	·	·	$-37M	$-98M	$-94M	$-26M	$-5M	·	·	·	$4M	·

Profitabilitas 8

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Gross Margin	43.2%	43.9%	41.3%	36.9%	38.6%	41.8%	48.1%	·	·	·	875.1%	·
Operating Margin	-15.9%	-13.9%	-18.2%	-30.9%	-24.5%	-3.1%	3.2%	·	·	·	-112.7%	·
Net Margin	-14.8%	-11.9%	-14.9%	-28.3%	-1.7%	0.94%	2.0%	·	·	·	-50.7%	·
Pretax Margin	-15.2%	-12.2%	-16.4%	-31.3%	-3.1%	-3.2%	0.89%	·	·	·	-89.8%	·
EBITDA Margin	-15.9%	-13.9%	-18.2%	-30.9%	-24.5%	-3.1%	3.2%	·	·	·	-112.7%	·
ROA	-7.2%	-4.7%	-5.1%	-8.0%	-0.58%	0.49%	1.3%	·	-0.25%	·	-1.1%	·
ROE	-12.8%	-8.7%	-9.3%	-14.3%	-0.74%	0.61%	1.6%	·	-0.50%	·	-1.9%	·
ROIC	-9.6%	-6.2%	-10.4%	-14.3%	-5.9%	0.60%	5.6%	·	0.21%	·	-1.2%	·

Likuiditas & Solvabilitas 5

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Current Ratio	4.3	2.0	6.2	6.7	7.8	6.1	4.5	·	2.4	·	2.5	·
Quick Ratio	3.6	1.7	4.9	4.3	4.9	4.6	4.2	·	2.1	·	1.8	·
Debt / Equity	0.4	0.6	·	·	·	0.0	·	·	0.5	·	0.3	·
LT Debt / Equity	0.4	0.4	·	·	·	·	·	·	0.5	·	0.2	·
Interest Coverage	·	·	-15.6	-104.7	-23.4	-2.0	3.5	·	·	·	-6.6	·

Efisiensi 3

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Asset Turnover	0.5	0.4	0.3	0.3	0.3	0.5	0.7	·	·	·	0.0	·
Inventory Turnover	14.9	14.6	14.3	13.5	11.2	11.8	18.4	·	20.1	·	14.5	·
Receivables Turnover	4.7	4.7	4.7	4.4	4.4	4.4	4.8	·	·	·	0.1	·

Per Saham 5

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Book Value / Share	$6.53	$7.08	$7.42	$8.04	$9.89	$6.63	$5.37	·	$2.15	·	$2.76	·
Revenue / Share	$5.68	$5.22	$4.71	$4.10	$4.04	$3.98	$3.95	·	·	·	$0.08	·
Cash Flow / Share	$0.04	$0.06	$-0.02	$-0.53	$-0.22	$0.01	$0.23	·	$0.23	·	$0.11	·
Cash / Share	$1.25	$2.88	$2.70	$2.12	$2.83	$2.18	$1.83	·	$0.16	·	$0.31	·
EPS (TTM)	$-0.24	$-0.24	$-0.24	$-0.24	$-0.24	$-0.24	$-0.24	$-0.24	$-0.24	$-0.24	$-0.04	$0.02

Tingkat Pertumbuhan 3

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue YoY	10.1%	11.7%	16.1%	5.2%	9.0%	·	·	·	·	·	·	·
Revenue CAGR 3Y	12.6%	10.9%	10.0%	·	·	·	·	·	·	·	·	·
Revenue CAGR 5Y	10.3%	·	·	·	·	·	·	·	·	·	·	·

Valuasi (TTM) 14

Metrik	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Revenue TTM	$727M	$661M	$592M	$510M	$484M	$444M	$409M	$277M	$240M	$232M	$5M	$5M
Net Income TTM	$-108M	$-79M	$-88M	$-144M	$-8M	$4M	$8M	$3M	$-396.0K	$-6M	$-3M	$1M
Market Cap	$1.51B	$2.10B	$2.05B	$1.15B	$3.82B	$5.64B	$2.76B	·	$713M	·	$597M	·
Enterprise Value	$1.69B	$2.27B	·	·	·	$5.41B	·	·	$795M	·	$626M	·
P/E	-49.0	-68.7	-67.4	-38.5	-142.2	-224.3	-121.9	-52.5	-36.9	-35.7	-196.8	208.5
P/S	2.1	3.2	3.5	2.2	7.9	12.7	6.8	·	3.0	·	119.3	·
P/B	1.8	2.3	2.2	1.1	3.5	8.1	5.4	·	4.1	·	2.8	·
P / Tangible Book	58.7	52.6	45.0	17.1	27.5	15.6	·	·	·	·	·	·
P / Cash Flow	288.1	298.9	-1051.4	-17.4	-143.1	3864.0	118.2	·	39.5	·	93.3	·
P / FCF	-69.2	-61.7	-66.9	-11.8	-42.1	-204.1	827.3	·	164.0	·	142.8	·
EV / EBITDA	-14.6	-24.7	·	·	·	-386.8	·	·	342.1	·	-111.1	·
EV / FCF	-77.6	-66.8	·	·	·	-195.9	·	·	182.9	·	149.9	·
EV / Revenue	2.3	3.4	·	·	·	12.2	·	·	3.3	·	125.2	·
Earnings Yield	-2.0%	-1.5%	-1.5%	-2.6%	-0.70%	-0.45%	-0.82%	-1.9%	-2.7%	-2.8%	-0.51%	0.48%

Laporan Laba Rugi 16

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue	$202M	$187M	$190M	$188M	$181M	$168M	$172M	$168M	$165M	$156M	$156M	$152M	$147M	$137M	$139M	$129M
Cost of Revenue	$110M	$106M	$107M	$107M	$104M	$95M	$95M	$93M	$92M	$91M	$88M	$90M	$87M	$82M	$82M	$80M
Gross Profit	$92M	$81M	$83M	$80M	$77M	$73M	$77M	$75M	$72M	$65M	$68M	$62M	$60M	$55M	$57M	$49M
R&D Expense	$11M	$10M	$9M	$9M	$9M	$10M	$8M	$8M	$8M	$8M	$7M	$5M	$8M	$7M	$7M	$7M
SG&A Expense	$64M	$66M	$64M	$70M	$72M	$68M	$64M	$67M	$63M	$66M	$60M	$61M	$60M	$62M	$55M	$64M
Operating Expenses	$102M	$99M	$97M	$107M	$125M	$101M	$96M	$96M	$94M	$96M	$86M	$87M	$90M	$90M	$83M	$88M
Operating Income	$-10M	$-18M	$-13M	$-27M	$-48M	$-28M	$-18M	$-21M	$-22M	$-31M	$-19M	$-24M	$-30M	$-35M	$-26M	$-40M
Interest Expense	·	·	·	·	·	·	·	·	·	$2M	·	$-3M	$-3M	$2M	·	$139.0K
Interest Income	$1M	$1M	$2M	$2M	$2M	$4M	$4M	$5M	$5M	$5M	$5M	$5M	$4M	$3M	·	·
Other Non-op	$-17.0K	$-12.0K	$84.0K	$-335.0K	$482.0K	$65.0K	$-431.0K	$317.0K	$-2.0K	$-263.0K	$124.0K	$-96.0K	$730.0K	$-114.0K	$-1.0K	$25.0K
Pretax Income	$2M	$-18M	$-12M	$-26M	$-46M	$-26M	$-16M	$-18M	$-19M	$-28M	$-15M	$-21M	$-27M	$-34M	$-26M	$-40M
Income Tax	$-412.0K	$-472.0K	$-3M	$740.0K	$-724.0K	$266.0K	$-804.0K	$-150.0K	$-375.0K	$-620.0K	$-960.0K	$-3M	$-2M	$-3M	$-3M	$-3M
Net Income	$2M	$-17M	$-10M	$-27M	$-45M	$-26M	$-15M	$-18M	$-19M	$-27M	$-14M	$-19M	$-24M	$-31M	$-23M	$-37M
Shares (Basic)	129,628,000	129,166,000	·	128,415,000	127,949,000	127,376,000	·	126,953,000	126,405,000	126,111,000	·	125,687,000	125,356,000	125,026,000	·	124,425,000
Shares (Diluted)	130,831,000	129,166,000	·	128,415,000	127,949,000	127,376,000	·	126,953,000	126,405,000	126,111,000	·	125,687,000	125,356,000	125,026,000	·	124,425,000
EBITDA	$-10M	$-18M	·	$-27M	$-48M	$-28M	·	$-21M	$-22M	$-31M	·	$-24M	$-30M	$-35M	·	$-40M

Neraca 27

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Cash & Equivalents	$146M	$146M	$160M	$164M	$155M	$346M	$367M	$362M	$355M	$332M	·	$306M	$289M	$276M	·	$266M
Receivables	$175M	$167M	$159M	$155M	$153M	$151M	$151M	$151M	$147M	$140M	·	$133M	$125M	$119M	·	$112M
Inventory	$27M	$30M	$29M	$28M	$34M	$30M	$27M	$24M	$23M	$20M	·	$24M	$25M	$24M	·	$24M
Prepaid Expense	$24M	$24M	$21M	$22M	$23M	$23M	$20M	$18M	$17M	$19M	·	$19M	$17M	$16M	·	$17M
Other Current Assets	$10M	$7M	$7M	$11M	$10M	$12M	$12M	$8M	$9M	$9M	·	$9M	$8M	$8M	·	$8M
Current Assets	$381M	$374M	$376M	$382M	$393M	$574M	$596M	$590M	$584M	$574M	·	$587M	$585M	$585M	·	$603M
PP&E (Net)	$81M	$84M	$85M	$85M	$85M	$90M	$94M	$93M	$92M	$88M	·	$95M	$100M	$103M	·	$107M
PP&E (Gross)	·	·	$294M	·	·	·	$284M	·	·	·	·	·	·	·	·	·
Accum. Depreciation	$223M	$216M	$209M	$209M	$201M	$199M	$190M	$181M	$176M	$168M	·	$155M	$147M	$139M	·	$125M
Goodwill	$524M	$524M	$524M	$524M	$524M	$523M	$523M	$523M	$523M	$523M	$523M	$523M	$523M	$523M	·	$523M
Intangibles	$271M	$279M	$287M	$294M	$302M	$331M	$340M	$348M	$356M	$365M	·	$382M	$391M	$399M	·	$417M
Other Non-current Assets	$9M	$10M	$9M	$8M	$7M	$6M	$6M	$6M	$4M	$4M	·	$5M	$5M	$5M	·	$7M
Total Assets	$1.35B	$1.35B	$1.36B	$1.37B	$1.39B	$1.60B	$1.64B	$1.64B	$1.64B	$1.64B	·	$1.68B	$1.70B	$1.71B	·	$1.76B
Accounts Payable	$21M	$26M	$23M	$23M	$27M	$16M	$22M	$17M	$17M	$18M	·	$17M	$18M	$23M	·	$14M
Current Liabilities	$106M	$85M	$88M	$98M	$100M	$280M	$301M	$296M	$290M	$77M	·	$93M	$95M	$87M	·	$85M
Capital Leases	$65M	$61M	$63M	$64M	$67M	$60M	$61M	$62M	$63M	$65M	·	$62M	$65M	$67M	·	$70M
Deferred Tax	$17M	$17M	$18M	$21M	$20M	$21M	$22M	$23M	$23M	$23M	·	$25M	$29M	$32M	·	$38M
Other Non-current Liabilities	$862.0K	$12M	$12M	$12M	$12M	$12M	$12M	$12M	$12M	$13M	·	$13M	$13M	$13M	·	$14M
Total Liabilities	$567M	$518M	$523M	$536M	$540M	$713M	$736M	$733M	$727M	$717M	·	$731M	$739M	$735M	·	$743M
Long-term Debt	·	·	$342M	·	·	·	$541M	·	·	·	·	·	·	·	·	·
Total Debt	$374M	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Retained Earnings	$-449M	$-451M	$-434M	$-424M	$-397M	$-352M	$-326M	$-310M	$-293M	$-274M	·	$-233M	$-214M	$-190M	·	$-136M
Treasury Stock	$25M	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·
AOCI	$4.0K	$4.0K	$4.0K	$71.0K	$29.0K	$-56.0K	$-206.0K	$-643.0K	$-1M	$-1M	·	$-2M	$-3M	$-3M	·	$-5M
Stockholders' Equity	$786M	$829M	$837M	$838M	$854M	$888M	$902M	$908M	$916M	$923M	$942M	$947M	$956M	$974M	$998M	$1.01B
Liabilities + Equity	$1.35B	$1.35B	$1.36B	$1.37B	$1.39B	$1.60B	$1.64B	$1.64B	$1.64B	$1.64B	·	$1.68B	$1.70B	$1.71B	·	$1.76B
Shares Outstanding	127,917,946	129,653,642	128,145,333	128,885,101	128,681,713	128,356,327	128,145,333	128,061,944	127,851,113	127,434,786	127,369,142	127,261,476	127,144,418	127,200,491	126,913,992	126,562,037

Arus Kas 13

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Stock-based Comp	$8M	$10M	$8M	$10M	$12M	$11M	$8M	$0	$9M	$8M	$7M	$0	$6M	$5M	$5M	$4M
Amort. of Intangibles	$8M	$8M	$8M	$8M	$8M	$8M	$8M	$8M	$8M	$8M	$9M	$9M	$9M	$9M	$9M	$8M
Restructuring	·	·	·	·	·	·	·	·	·	$2M	$1M	$2M	$3M	$5M	·	$0
Operating Cash Flow	$20M	$-8M	$1M	$9M	$20M	$-25M	$10M	$9M	$14M	$-26M	$18M	$-5M	$-2M	$-13M	$-4M	$-16M
CapEx	$8M	$5M	$8M	$8M	$6M	$4M	$12M	$11M	$13M	$6M	$7M	$4M	$7M	$10M	$5M	$8M
Investing Cash Flow	$-8M	$-5M	$-6M	$-277.0K	$-9M	$4M	$-5M	$-4M	$7M	$15M	$17M	$21M	$15M	$24M	$-1M	$-4M
Stock Issued	$2M	$-338.0K	$431.0K	$765.0K	$-1M	$949.0K	$687.0K	$1M	$2M	$816.0K	$1M	$2M	$93.0K	$1M	$2M	$3M
Net Stock Activity	·	$-338.0K	·	·	·	$949.0K	·	·	·	$816.0K	·	·	·	$1M	·	·
Financing Cash Flow	$-12M	$-338.0K	$431.0K	$765.0K	$-202M	$949.0K	$687.0K	$1M	$2M	$816.0K	$1M	$2M	$64.0K	$1M	$2M	$3M
Net Change in Cash	·	·	·	$9M	·	·	·	$7M	$23M	$-11M	·	$17M	$13M	$12M	·	$-18M
Taxes Paid	$711.0K	$0	$57.0K	$0	$458.0K	$0	$-112.0K	$143.0K	$87.0K	$89.0K	$0	$0	$175.0K	$0	$25.0K	$26.0K
Free Cash Flow	·	$-13M	·	·	·	$-30M	·	·	·	$-32M	·	·	·	$-23M	·	·
Levered FCF	·	·	·	·	·	·	·	·	·	$-33M	·	·	·	·	·	·

Profitabilitas 8

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Gross Margin	45.6%	43.3%	·	42.8%	42.6%	43.6%	·	44.6%	44.1%	41.9%	·	41.0%	40.8%	40.0%	·	38.0%
Operating Margin	-4.9%	-9.8%	·	-14.4%	-26.3%	-16.6%	·	-12.6%	-13.3%	-19.6%	·	-15.9%	-20.3%	-25.6%	·	-30.7%
Net Margin	1.1%	-9.2%	·	-14.4%	-24.9%	-15.4%	·	-10.5%	-11.3%	-17.3%	·	-12.2%	-16.6%	-22.4%	·	-28.6%
Pretax Margin	0.91%	-9.4%	·	-14.1%	-25.3%	-15.3%	·	-10.6%	-11.6%	-17.7%	·	-14.1%	-18.1%	-24.6%	·	-30.8%
EBITDA Margin	-4.9%	-9.8%	·	-14.4%	-26.3%	-16.6%	·	-12.6%	-13.3%	-19.6%	·	-15.9%	-20.3%	-25.6%	·	-30.7%
ROA	0.16%	-1.2%	·	-1.8%	-3.0%	-1.6%	·	-1.1%	-1.1%	-1.6%	·	-1.1%	-1.4%	-1.7%	·	-2.0%
ROE	0.27%	-2.0%	·	-3.1%	-5.1%	-2.9%	·	-1.9%	-2.0%	-2.9%	·	-1.9%	-2.4%	-3.0%	·	-3.4%
ROIC	-1.0%	-2.1%	·	-3.3%	-5.5%	-3.2%	·	-2.3%	-2.4%	-3.2%	·	-2.2%	-2.9%	-3.3%	·	-3.6%

Likuiditas & Solvabilitas 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Current Ratio	3.6	4.4	·	3.9	3.9	2.1	·	2.0	2.0	7.5	·	6.3	6.2	6.8	·	7.1
Quick Ratio	3.0	3.7	·	3.3	3.1	1.8	·	1.7	1.7	6.2	·	4.7	4.4	4.6	·	4.4
Debt / Equity	0.5	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·
LT Debt / Equity	0.5	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Interest Coverage	·	·	·	·	·	·	·	·	·	-18.1	·	8.5	11.8	·	·	-284.2

Efisiensi 3

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Asset Turnover	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1	0.1	0.1	·	0.1
Inventory Turnover	3.6	3.6	·	4.1	3.6	3.8	·	3.8	3.8	4.1	·	3.7	3.7	3.4	·	3.5
Receivables Turnover	1.2	1.2	·	1.2	1.2	1.2	·	1.2	1.2	1.2	·	1.2	1.2	1.2	·	1.2

Per Saham 5

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Book Value / Share	$6.14	$6.39	·	$6.50	$6.64	$6.92	·	$7.09	$7.16	$7.25	·	$7.44	$7.52	$7.66	·	$8.00
Revenue / Share	$1.54	$1.45	·	$1.46	$1.42	$1.32	·	$1.32	$1.30	$1.24	·	$1.21	$1.17	$1.10	·	$1.03
Cash Flow / Share	·	$-0.06	·	·	·	$-0.20	·	·	·	$-0.21	·	·	·	$-0.10	·	·
Cash / Share	$1.14	$1.13	·	$1.27	$1.20	$2.70	·	$2.83	$2.78	$2.60	·	$2.41	$2.27	$2.17	·	$2.10
EPS (TTM)	$-0.24	$-0.24	·	$-0.24	$-0.24	$-0.24	·	$-0.24	$-0.24	$-0.24	·	$-0.24	$-0.24	$-0.24	·	$-0.24

Valuasi (TTM) 11

Metrik	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Revenue TTM	$766M	$746M	·	$709M	$689M	$672M	·	$644M	$628M	$611M	·	$575M	$552M	$530M	·	$497M
Net Income TTM	$-52M	$-99M	·	$-113M	$-104M	$-78M	·	$-78M	$-79M	$-84M	·	$-96M	$-115M	$-126M	·	$-163M
Market Cap	$1.87B	$962M	·	$995M	$941M	$1.22B	·	$1.89B	$1.77B	$2.00B	·	$1.57B	$2.04B	$2.21B	·	$1.09B
Enterprise Value	$2.10B	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·
P/E	-60.8	-30.9	·	-32.2	-30.5	-39.5	·	-61.5	-57.8	-65.5	·	-51.2	-67.0	-72.5	·	-35.9
P/S	2.4	1.3	·	1.4	1.4	1.8	·	2.9	2.8	3.3	·	2.7	3.7	4.2	·	2.2
P/B	2.4	1.2	·	1.2	1.1	1.4	·	2.1	1.9	2.2	·	1.7	2.1	2.3	·	1.1
P / Tangible Book	·	37.2	·	50.3	33.5	35.6	·	50.5	48.3	55.8	·	36.6	47.8	42.4	·	14.9
P / Cash Flow	·	-118.2	·	·	·	-48.1	·	·	·	-77.3	·	·	·	-174.5	·	·
EV / Revenue	2.7	·	·	·	·	·	·	·	·	·	·	·	·	·	·	·
Earnings Yield	-1.6%	-3.2%	·	-3.1%	-3.3%	-2.5%	·	-1.6%	-1.7%	-1.5%	·	-1.9%	-1.5%	-1.4%	·	-2.8%

Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

16

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Pendapatan	$727M	$661M	$592M	$510M	$484M
Margin Kotor %	43.2%	43.9%	41.3%	36.9%	38.6%
Margin Operasi %	-15.9%	-13.9%	-18.2%	-30.9%	-24.5%
Laba Bersih	$-108M	$-79M	$-88M	$-144M	$-8M

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Utang / Ekuitas	0.4	0.6	·	·	·
Rasio Lancar	4.3	2.0	6.2	6.7	7.8
Rasio Cepat	3.6	1.7	4.9	4.3	4.9

Metrik	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Arus Kas Bebas	$-22M	$-34M	$-31M	$-97M	$-91M

Pemilik institusional (13F) 296 pengaju · $2.4B total · Per tanggal 30 Sep. 2026

17

Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.

Pemegang 296

Nilai yang dipegang $2.4B

Posisi baru 58

Posisi yang keluar 38

Aktivitas institusional — Q2 2026 vs kuartal sebelumnya

Posisi baru	Posisi yang keluar	Meningkat	Menurun	Perubahan bersih saham
58 (+9 vs Kuartal sebelumnya)	38 (+2 vs Kuartal sebelumnya)	100 (+22 vs Kuartal sebelumnya)	61 (-22 vs Kuartal sebelumnya)	+19.6M

Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.

Institusi	Nilai	Saham	% dari 13F yang dilacak	Tipe
BlackRock, Inc.	$304.469.400	20.868.362	12,94%	Saham
First Light Asset Management, LLC	$179.158.241	12.279.523	7,61%	Saham
VANGUARD GROUP INC	$162.621.455	13.828.355	6,91%	Saham
FIRST TRUST ADVISORS LP	$147.552.477	10.113.261	6,27%	Saham
Greenhouse Funds LLLP	$125.097.724	8.574.210	5,32%	Saham
VANGUARD PORTFOLIO MANAGEMENT LLC	$117.615.272	8.061.362	5,00%	Saham
VANGUARD CAPITAL MANAGEMENT LLC	$84.082.418	5.763.017	3,57%	Saham
STATE STREET CORP	$78.257.609	5.363.784	3,33%	Saham
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.	$73.501.000	5.037.787	3,12%	Saham
BRAIDWELL LP	$71.756.567	4.918.202	3,05%	Saham
SCHRODER INVESTMENT MANAGEMENT GROUP	$61.886.083	4.342.883	2,63%	Saham
SUSQUEHANNA INTERNATIONAL GROUP, LLP	$50.558.727	3.465.300	2,15%	Opsi beli
GEODE CAPITAL MANAGEMENT, LLC	$50.025.999	3.428.123	2,13%	Saham
MILLENNIUM MANAGEMENT LLC	$44.930.518	3.079.542	1,91%	Saham
TORONTO DOMINION BANK	$43.770.000	3.000.000	1,86%	Opsi beli
LOOMIS SAYLES & CO L P	$37.025.291	2.537.717	1,57%	Saham
Driehaus Capital Management LLC	$36.604.049	2.508.845	1,56%	Saham
BANK OF AMERICA CORP /DE/	$35.546.038	2.436.329	1,51%	Saham
DIMENSIONAL FUND ADVISORS LP	$35.003.708	2.399.411	1,49%	Saham
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP	$34.896.129	2.391.784	1,48%	Saham
AMERICAN CAPITAL MANAGEMENT INC	$32.648.145	2.237.707	1,39%	Saham
UBS Group AG	$32.581.659	2.233.150	1,38%	Opsi beli
D. E. Shaw & Co., Inc.	$32.021.519	2.194.758	1,36%	Saham
SAMLYN CAPITAL, LLC	$31.096.207	2.131.337	1,32%	Saham
Aberdeen Group plc	$28.180.950	1.931.525	1,20%	Saham
MORGAN STANLEY	$27.693.709	1.898.128	1,18%	Saham
GOLDMAN SACHS GROUP INC	$22.859.028	1.566.760	0,97%	Saham
NORTHERN TRUST CORP	$22.456.651	1.539.181	0,95%	Saham
GLENMEDE TRUST CO NA	$22.141.579	1.517.586	0,94%	Saham
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	$17.689.018	1.212.407	0,75%	Saham
SEGALL BRYANT & HAMILL, LLC	$15.850.518	1.086.396	0,67%	Saham
VANGUARD FIDUCIARY TRUST CO	$12.685.640	869.475	0,54%	Saham
AQR CAPITAL MANAGEMENT LLC	$12.149.312	832.715	0,52%	Saham
Glenmede Investment Management, LP	$12.057.018	1.561.790	0,51%	Saham
Connor, Clark & Lunn Investment Management Ltd.	$11.709.890	802.597	0,50%	Saham
Bank of New York Mellon Corp	$10.743.609	736.368	0,46%	Saham
CITIGROUP INC	$9.748.716	668.178	0,41%	Saham
PRINCIPAL FINANCIAL GROUP INC	$9.189.162	629.826	0,39%	Saham
HighMark Wealth Management LLC	$8.936.871	612.534	0,38%	Saham
Invesco Ltd.	$8.754.555	600.038	0,37%	Saham
UBS Group AG	$8.391.672	575.166	0,36%	Saham
JPMORGAN CHASE & CO	$8.363.938	581.091	0,36%	Saham
JUPITER ASSET MANAGEMENT LTD	$7.841.935	537.487	0,33%	Saham
Public Sector Pension Investment Board	$6.526.545	447.330	0,28%	Saham
Trexquant Investment LP	$6.358.074	435.783	0,27%	Saham
Nuveen, LLC	$6.172.300	423.050	0,26%	Saham
Granite Investment Partners, LLC	$5.181.507	355.141	0,22%	Saham
AMERIPRISE FINANCIAL INC	$4.625.865	317.057	0,20%	Saham
RHUMBLINE ADVISERS	$4.624.054	316.935	0,20%	Saham
Legal & General Group Plc	$4.317.503	295.922	0,18%	Saham

Tampilkan semua 296 pemilik institusional →

Aktivis & pemilik 5%+ 1 saham

18

Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.

Pengaju	Diajukan	Kepemilikan	Status	Tujuan	Pengajuan
IRS IDENTIFICATION NO. NeoGenomics, Inc.	12 April 2007	·	Pengajuan awal	·	SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Orang dalam perusahaan 52 orang dalam · 31 pejabat · 23 direktur

19

Orang Dalam	Peran	Aktivitas terakhir	Saham dimiliki	Jual 12m	Bersih 12m
Anthony P. Zook	Chief Executive Officer	1 April 2026 M	133.111	0	$0
Christopher M Smith	Chief Executive Officer	23 Feb. 2025 M	641.585	0	$0
Mark Mallon	Chief Executive Officer	1 Maret 2022 A	368.051	0	$0
Jeffrey Scott Sherman	Chief Financial Officer	23 Feb. 2026 M	220.009	0	$0
William Bonello	Chief Financial Officer	28 April 2022 M	191.548	0	$0
Sharon Virag	Chief Financial Officer	1 Maret 2019 A	10.944	0	$0
Vishal Sikri	President Advanced Diagnostics	23 Feb. 2024 A	127.716	0	$0
David Sholehvar	President, Clinical Services	1 Agu 2022 A	43.216	0	$0
George Cardoza	President & COO, Lab Ops	2 Maret 2022 F	244.157	0	$0
Gina M Wallar	President, Pharma Services	1 Maret 2022 A	33.443	0	$0
Clive Morris	President of Inivata	30 Des. 2021 A	41.280	0	$0
Robert J. Shovlin	President, Clinical Services	25 Mei 2021 M	150.101	0	$0
Warren Stone	Pres & Chief Operating Officer	21 Agu 2026 M	181.078	1	$-276.600
Alicia C Olivo	EVP, GC & Business Development	1 Sep. 2026 F	90.875	2	$-300.172
Greg D Aunan	Chief Accounting Officer	4 Agu 2026 S	5.153	1	$-321.400
Melody Harris	Chf Ops Off, Pres, Informatics	23 Feb. 2025 M	109.755	0	$0
Shashikant Kulkarni	Chief Scientific Officer	1 April 2023 F	82.673	0	$0
Cynthia J Dieter	Chief Accounting Officer	2 Maret 2023 F	29.765	0	$0
Douglas Matthew Brown	Chief Strategy Officer	1 April 2022 A	158.684	0	$0
Halley E Gilbert	Chief Legal Officer	1 Maret 2022 A	147.396	0	$0
Kathryn B Mckenzie	Chief Sustainability/Risk Ofcr	11 Jan. 2022 M	49.361	0	$0
Jennifer Balliet	VP and Chief Culture Officer	30 Des. 2021 A	48.615	0	$0
Lawrence Martin Weiss	Chief Medical Officer	22 April 2021 M	130.847	0	$0
Denise E Pedulla	General Counsel	2 Maret 2021 A	60.643	0	$0
Steven G. Brodie	VP - Pharma Operations	22 Okt. 2018 M	45.953	0	$0
Steven A Ross	CIO	10 Mei 2018 X	4.500	0	$0
Maher Albitar	Chief Medical Officer	25 Mei 2017 A	60.692	0	$0
Mark Alan Machulcz	Vice President of Operations	28 Jan. 2016 A	·	0	$0
Robert H. Horel	Vice President GM PathLogic	29 Des. 2015 X	51.218	0	$0
Robert P Gasparini	Chief Science Officer	22 Mei 2014 X	8.439	0	$0
Mark W Smits	Chief Commercial Officer	18 Mei 2011 M	0	0	$0
Carolyn S Starrett	Direktur	23 Juni 2026 A	·	0	$0
Lynn A. Tetrault	Direktur	15 Juni 2026 S	86.115	2	$-118.824
Marjorie C Green	Direktur	1 Juni 2026 A	22.964	0	$0
Neil Gunn	Direktur	1 Juni 2026 A	51.177	0	$0
Michael Aaron Kelly	Direktur	1 Juni 2026 A	67.086	0	$0
David Brian Perez	Direktur	1 Juni 2026 A	56.967	0	$0
John P. Kenny	Direktur	1 Juni 2026 A	5.893	0	$0
Stephen M Kanovsky	Direktur	1 Juni 2026 A	75.421	0	$0
Felicia Williams	Direktur	1 Juni 2026 A	30.237	0	$0
Elizabeth Floegel	Direktur	1 Juni 2025 A	23.590	0	$0
Alison L. Hannah	Direktur	1 Juni 2025 M	131.023	0	$0
Bruce K Crowther	Direktur	10 Agu 2023 A	65.120	0	$0
Rachel A Stahler	Direktur	10 Juni 2022 A	21.335	0	$0
David Daly	Direktur	10 Juni 2022 A	17.179	0	$0
Kevin C Johnson	Direktur	22 Des. 2021 M	37.398	0	$0
Douglas M Van Oort	Direktur	1 Agu 2021 F	2.468.797	0	$0
Steven C Jones	Direktur	7 Jan. 2021 M	90.218	0	$0
Raymond R Hipp	Direktur	16 Nov. 2020 S	66.800	0	$0
William J Robison	Direktur	25 Mei 2017 A	183.348	0	$0
Michael T Dent	Direktur	4 Des. 2014 S	1.384.150	0	$0
Peter M Peterson	Direktur	5 Juni 2012 A	34.500	0	$0

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Kepemilikan ETF Dimiliki oleh 51 ETF

20

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana	Bobot	Unit	Per tanggal	Sumber
PSCH · Invesco Exchange-Traded Fund Trust …	1,27%	123.482 SH	1 Okt. 2026	Harian
PTH · Invesco Exchange-Traded Fund Trust	1,23%	246.967 SH	1 Okt. 2026	Harian
XSMO · Invesco Exchange-Traded Fund Trust	0,84%	1.312.803 SH	1 Okt. 2026	Harian
FYC · First Trust Exchange-Traded AlphaDE…	0,71%	601.468 NS	31 Juli 2026	N-PORT
IHF · iShares Trust	0,34%	250.331 SH	11 Sep. 2026	Harian
FYX · First Trust Exchange-Traded AlphaDE…	0,27%	239.159 NS	31 Juli 2026	N-PORT
QVMS · Invesco Exchange-Traded Fund Trust …	0,16%	19.929 SH	1 Okt. 2026	Harian
NUSC · Nushares ETF Trust	0,15%	126.293 NS	31 Juli 2026	N-PORT
FAD · First Trust Exchange-Traded AlphaDE…	0,14%	54.487 NS	31 Juli 2026	N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust	0,12%	180.254 SH	1 Okt. 2026	Harian
VIOG · VANGUARD ADMIRAL FUNDS	0,12%	89.895 SH	19 Agu 2026	Harian
VTWV · VANGUARD SCOTTSDALE FUNDS	0,11%	104.297 SH	19 Agu 2026	Harian
VIOO · VANGUARD ADMIRAL FUNDS	0,10%	455.144 SH	19 Agu 2026	Harian
ESML · iShares Trust	0,09%	146.435 SH	11 Sep. 2026	Harian
VIOV · VANGUARD ADMIRAL FUNDS	0,09%	116.046 SH	19 Agu 2026	Harian
JPSE · J.P. Morgan Exchange-Traded Fund Tr…	0,09%	33.444 NS	31 Juli 2026	N-PORT
IWM · iShares Trust	0,08%	3.367.792 SH	11 Sep. 2026	Harian
BBSC · J.P. Morgan Exchange-Traded Fund Tr…	0,08%	34.215 NS	31 Juli 2026	N-PORT
ISCG · iShares Trust	0,07%	40.558 SH	11 Sep. 2026	Harian
RSSL · Global X Funds	0,06%	63.019 NS	31 Juli 2026	N-PORT
VTWO · VANGUARD SCOTTSDALE FUNDS	0,06%	757.699 SH	19 Agu 2026	Harian
SMDX · Tidal Trust III	0,05%	4.493 NS	31 Juli 2026	N-PORT
RWJ · Invesco Exchange-Traded Fund Trust …	0,05%	54.996 SH	1 Okt. 2026	Harian
VBK · VANGUARD INDEX FUNDS	0,05%	1.728.845 SH	19 Agu 2026	Harian
DFAS · Dimensional ETF Trust	0,04%	358.850 NS	31 Juli 2026	N-PORT
VHT · VANGUARD WORLD FUND	0,03%	388.986 SH	19 Agu 2026	Harian
WSML · iShares Trust	0,03%	10.624 SH	11 Sep. 2026	Harian
FHLC · FIDELITY COVINGTON TRUST	0,03%	62.331 NS	31 Juli 2026	N-PORT
DXUV · Dimensional ETF Trust	0,02%	8.379 NS	31 Juli 2026	N-PORT
VXF · VANGUARD INDEX FUNDS	0,02%	1.492.431 SH	19 Agu 2026	Harian
VB · VANGUARD INDEX FUNDS	0,02%	2.990.594 SH	19 Agu 2026	Harian
IWO · iShares Trust	0,01%	115.979 SH	11 Sep. 2026	Harian
DFAC · Dimensional ETF Trust	0,01%	344.253 NS	31 Juli 2026	N-PORT
DFSU · Dimensional ETF Trust	0,01%	15.340 NS	31 Juli 2026	N-PORT
VTWG · VANGUARD SCOTTSDALE FUNDS	0,01%	12.627 SH	19 Agu 2026	Harian
DCOR · Dimensional ETF Trust	0,01%	14.534 NS	31 Juli 2026	N-PORT
DFAU · Dimensional ETF Trust	0,00%	30.125 NS	31 Juli 2026	N-PORT
DFUS · Dimensional ETF Trust	0,00%	47.070 NS	31 Juli 2026	N-PORT
ITOT · iShares Trust	0,00%	172.474 SH	11 Sep. 2026	Harian
TILT · FlexShares Trust	0,00%	4.536 NS	31 Juli 2026	N-PORT
IWV · iShares Trust	0,00%	35.356 SH	10 Sep. 2026	Harian
IXUS · iShares Trust	0,00%	56.854 SH	11 Sep. 2026	Harian
VTI · VANGUARD INDEX FUNDS	0,00%	4.136.535 SH	19 Agu 2026	Harian
VTHR · VANGUARD SCOTTSDALE FUNDS	0,00%	10.236 SH	19 Agu 2026	Harian
IJR · iShares Trust	·	7.951.677 SH	10 Sep. 2026	Harian
IJT · iShares Trust	·	716.232 SH	9 Sep. 2026	Harian
IJS · iShares Trust	·	490.259 SH	8 Sep. 2026	Harian
IWN · iShares Trust	·	1.129.992 SH	11 Sep. 2026	Harian
XJR · iShares Trust	·	18.003 SH	31 Agu 2026	Harian
ISCB · iShares Trust	·	5.811 SH	11 Sep. 2026	Harian
SMLF · iShares Trust	·	45.624 SH	11 Sep. 2026	Harian

NEO Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

21

peringkat · 16 analis BELI

Target median $19.00 +2,9%

4 25,0% Beli Kuat

7 43,8% Beli

5 31,2% Tahan

0 0,0% Jual

0 0,0% Jual Kuat

Target Harga 12 Bulan

9 analis · 2026-10-02

Target rata-rata $19.72 +6,8%

Sekarang Harga saat ini $18.47

Rendah$16.00 Rata-rata$19.72 Tinggi$35.00

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

22

Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.

Ticker	Kapitalisasi Pasar	P/E	Pendapatan YoY	Margin Bersih	ROE	Margin Kotor
NEO	$1.51B	-49.0	10.1%	-14.8%	-12.8%	43.2%
OPCH	$5.00B	25.1	13.0%	3.7%	15.4%	19.3%
AVAH	$1.70B	7.7	20.2%	9.2%	246.6%	33.3%
GRDN	·	·	17.9%	3.4%	24.8%	20.2%
PRVA	$2.93B	131.7	22.3%	1.1%	3.3%	·
MD	$1.77B	11.0	-4.9%	8.6%	20.3%	·
ADUS	·	20.6	23.2%	·	·	·
WGS	·	·	·	·	·	·
ASTH	$1.21B	53.9	56.4%	0.71%	3.0%	·
AMN	$606M	-6.4	-8.5%	-3.5%	-15.3%	28.3%

Berita Terbaru Berita utama terbaru yang menyebutkan perusahaan ini

23

Jersey Oil and Gas siap untuk membuka nilai - broker Yahoo Finance · 4 bulan, 2 minggu lalu

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

26

Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

NEO NeoGenomics, Inc. - Common Stock